Nuclear or cytoplasmic expression of survivin: What is the significance? von Li, Fengzhi, Yang, Jie, Ramnath, Nithya, Javle, Milind M., Tan, Dongfeng

Volltext

Risk factors associated with earlier age of onset in familial pancreatic carcinoma von James, Ted A., Sheldon, David G., Rajput, Ashwani, Kuvshinoff, Boris W., Javle, Milind M., Nava, Hector R., Smith, Judy L., Gibbs, John F.

Volltext

Should adjuvant therapy remain the standard of care for patients with resected adenocarcinoma of the pancreas? von Chu, Quyen D, Khushalani, Nikhil, Javle, Miland M, Douglass, Jr, Harold O, Gibbs, John F

Volltext

S-phase modulation by irinotecan : pilot studies in advanced solid tumors von RAMNATH, N, KHUSHALANI, N, JAVLE, M. M, BERDZIK, J, CREAVEN, P. J, RUSTUM, Y. M, TOTH, K, LITWIN, A. M, INTENGAN, M. E, SLOCUM, H. K, PENDYALA, L, SMITH, P. F, STEWART, C. C, HOFFMAN, J. L

Volltext

Management of locoregional stage esophageal cancer: a single center experience von Javle, M. M., Nwogu, C. E., Donohue, K. A., Iyer, R. V., Brady, W. E., Khemka, S. V., Smith, J. L., Demmy, T. L., Yang, G. Y., Nava, H. R.

Volltext

Postoperative computed tomography scan surveillance for patients with stage II and III colorectal cancer: worthy of further study? von Mortazavi, Amir, Shaukat, Aasma, Othman, Edress, Kepner, James L, Fakih, Marwan G, Kuvshinoff, Boris W, Smith, Judy L, Javle, Milind M

Volltext

Case 3. Gastric signet ring carcinoma presenting as a diffuse thigh mass von VARMA, Geetha N, WINSTON, Janet S, HILL, Hank C, GIBBS, John F, PROULX, Gary M, MCGRATH, Brian E, JAVLE, Milind M

Volltext

Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial von Zhu, AX, Macarulla, T, Javle, MM, Kelley, RK, Lubner, SJ, Adeva, J, Cleary, JM, Catenacci, DVT, Borad, MJ, Bridgewater, JA, Harris, WP, Murphy, AG, Oh, D-Y, Whisenant, JR, Lowery, MA, Goyal, L, Shroff, RT, El-Khoueiry, AB, Chamberlain, CX, Aguado-Fraile, E, Choe, S, Wu, B, Liu, H, Gliser, C, Pandya, SS, Valle, JW, Abou-Alfa, GK

Volltext bestellen

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study von Abou-Alfa, GK, Macarulla, T, Javle, MM, Kelley, RK, Lubner, SJ, Adeva, J, Cleary, JM, Catenacci, DV, Borad, MJ, Bridgewater, J, Harris, WP, Murphy, AG, Oh, D-Y, Whisenant, J, Lowery, MA, Goyal, L, Shroff, RT, El-Khoueiry, AB, Fan, B, Wu, B, Chamberlain, CX, Jiang, L, Gliser, C, Pandya, SS, Valle, JW, Zhu, AX

Volltext bestellen

552 Characteristics of the tumor microenvironment in IDH1-mutated cholangiocarcinoma patients from ClarIDHy trial von Saatcioglu, H Duygu, Valle, Juan, Macarulla, Teresa, Javle, Milind, Do-Youn, Oh, Goyal, Lipika, Conway, Jake, Iyer, Janani, Najdawi, Fedaa, Shah, Chintan, Gliser, Camelia, Pandya, Susan, Daigle, Scott, Abou-Alfa, Ghassan, Kelley, Robin

Volltext

Comparing the outcome of doublet therapy (gemcitabine and cisplatin) with triplet therapy (gemcitabine, cisplatin and nab paclitaxel) in locally advanced or metastatic gall bladder... von Khatri, Chandrani, Das, Pratap K., Patowary, Jayanta

Volltext

FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma von King, Gentry, Javle, Milind

Volltext

944 Fibroblasts as paracrine targets of the oncometabolite D-2-HG in the IDH1-mutant cholangiocarcinoma tumor microenvironment von Zabransky, Daniel, Jain, Prerna, Mody, Kabir, El-Refai, Sherif, Jaffee, Elizabeth, Yarchoan, Mark

Volltext

Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study von Javle, Milind, Borad, Mitesh J, Azad, Nilofer S, Kurzrock, Razelle, Abou-Alfa, Ghassan K, George, Ben, Hainsworth, John, Meric-Bernstam, Funda, Swanton, Charles, Sweeney, Christopher J, Friedman, Claire F, Bose, Ron, Spigel, David R, Wang, Yong, Levy, Jonathan, Schulze, Katja, Cuchelkar, Vaikunth, Patel, Arisha, Burris, Howard

Volltext

Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers von Singhi, Aatur D., George, Ben, Greenbowe, Joel R., Chung, Jon, Suh, James, Maitra, Anirban, Klempner, Samuel J., Hendifar, Andrew, Milind, Javle M., Golan, Talia, Brand, Randall E., Zureikat, Amer H., Roy, Somak, Schrock, Alexa B., Miller, Vincent A., Ross, Jeffrey S., Ali, Siraj M., Bahary, Nathan

Volltext

Molecular profiling of biliary tract cancer: a target rich disease von Jain, Apurva, Javle, Milind

Volltext

Biliary cancer: Utility of next‐generation sequencing for clinical management von Javle, Milind, Bekaii‐Saab, Tanios, Jain, Apurva, Wang, Ying, Kelley, Robin Katie, Wang, Kai, Kang, Hyunseon C., Catenacci, Daniel, Ali, Siraj, Krishnan, Sunil, Ahn, Daniel, Bocobo, Andrea Grace, Zuo, Mingxin, Kaseb, Ahmed, Miller, Vincent, Stephens, Philip J., Meric‐Bernstam, Funda, Shroff, Rachna, Ross, Jeffrey

Volltext

Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma von Kunkeaw, N, Jeon, S H, Lee, K, Johnson, B H, Tanasanvimon, S, Javle, M, Pairojkul, C, Chamgramol, Y, Wongfieng, W, Gong, B, Leelayuwat, C, Lee, Y S

Volltext

Prognostic value of carbohydrate antigen 19‐9 in patients undergoing resection of biliary tract cancer von Yamashita, S., Passot, G., Aloia, T. A., Chun, Y. S., Javle, M., Lee, J. E., Vauthey, J.‐N., Conrad, C.

Volltext

Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice von Jain, Apurva, Kwong, Lawrence N, Javle, Milind

Volltext